WeVote
Log In

Bill

Bill

S 10340

Requires reporting of the tick-borne disease of Alpha-gal syndrome

2025 Regular Session Introduced by Rachel May

The bill would make Alpha-gal syndrome a reportable disease in New York and require mandatory reporting of diagnosed cases, while adding AGS to the state’s tick-borne disease surve

SUBSTITUTED BY A11328
0
WeVote Research Nonpartisan
Bill Summary · S 10340

Overview

Bill S. 10340 (2025-2026, New York) proposes adding Alpha-gal syndrome (AGS) to New York’s list of reportable tick-borne diseases. The measure would require health care practitioners and facilities to report diagnosed cases of AGS and would expand the state’s tick-borne disease surveillance to include AGS in its reporting.

Purpose and intent

  • Establish Alpha-gal syndrome as a reportable condition in New York.
  • Ensure AGS diagnoses are systematically reported to state public health authorities.
  • Expand the tick-borne disease surveillance report to include AGS, improving tracking and public health response.

Key provisions

  • New Section 206-c added to the Public Health Law:
    1. The commissioner must promulgate rules and regulations to designate Alpha-gal syndrome as a reportable disease or condition. This creates mandatory reporting for diagnosed cases by health care practitioners and facilities.
    2. The commissioner must expand the existing tick-borne disease surveillance list to include Alpha-gal syndrome within the department’s tick-borne disease surveillance report (maintained by the Bureau of Communicable Disease Control).
  • Effective date: The act becomes law 180 days after enactment.

Affected parties and impacts

  • Health care practitioners (physicians, clinicians, and other medical professionals) and health care facilities in New York:
    • Will be required to report diagnosed AGS cases.
  • Public health authorities and surveillance programs:
    • Will receive ongoing AGS case data, integrating AGS into the existing tick-borne disease surveillance framework.
  • General public:
    • Potential for improved monitoring and understanding of AGS incidence, trends, and associated public health responses.

Procedural and timeline notes

  • Status: Introduced May 14, 2026; referred to Health; subsequently discharged from committee and committed to Rules; substituted by A11328 for floor consideration (as of June 1, 2026).
  • Effective date: 180 days after enactment.
  • Next steps if enacted: Commissioner would issue rules/regulations to implement reporting requirements and would update the surveillance report to include AGS.

Summary

This bill aims to formalize Alpha-gal syndrome as a reportable condition in New York and to incorporate AGS into the state’s tick-borne disease surveillance system. By mandating reporting of AGS diagnoses and expanding the surveillance framework, the state seeks to improve data collection, monitoring, and public health responses to AGS.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.